Vitamin D deficiency may increase the chance of muscle injuries in elite athletes, specifically NFL football players, suggested a recent study presented last week at the American Orthopaedic Society for Sports Medicine’s annual meeting.
A once-monthly formulation of a drug made by Amylin Pharmaceuticals, Eli Lilly and Alkermes improved glucose control in patients with Type 2 diabetes, according to results of a mid-stage clinical trial presented at the American Diabetes Association’s 71st Scientific Sessions.
Patients with Type 1 diabetes using an insulin product made by MannKind expressed a better opinion about insulin therapy than those taking the standard treatment, according to a study presented at the American Diabetes Association’s 71st Scientific Sessions.
MediShield was selected as a winner of the 11th Annual New York Venture Summit Top Innovator award last month by YoungStartup Ventures. The award recognizes privately held companies from across the United States that play a leading role in innovation.
Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.
An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.
Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.
An insulin product made by Eli Lilly appears likely to be more cost-effective than long-acting insulin analog, according to a study presented Friday at the American Diabetes Association’s 71st Scientific Sessions in San Diego.
Drug Store News editor-in-chief Rob Eder interviewed Lansinoh Labs VP sales Michelle McLaughlin here at NACDS Marketplace about the company’s leading position in the natural feeding category, and an exciting new line of products from Europe, which Lansinoh acquired this year and currently is launching to U.S. retailers.
HealthPrize Technologies and RealAge will launch a study next month that will test HealthPrize’s medication adherence technologies on patients taking asthma medications, the two companies said Wednesday.
Between 1965 and 2007, the number of people with a pack-a-day habit significantly declined, as did the number of people who smoked 10 or more cigarettes a day, according to a study in the March 16 issue of the Journal of the American Medical Association.
The nurse practitioner-staffed retail clinic concept has sparked a revolution in health care, and now even physicians are re-examining the model to find new ways to create value and improve healthcare delivery.
Aisle411, a mobile retail navigation service that helps shoppers locate products down to the shelf location, on Tuesday announced its service now is live in more than 1,000 stores. The service added three markets: Las Vegas, Los Angeles and San Diego.